Countdown to HealthEquity (HQY) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
Werte in diesem Artikel
Wall Street analysts expect HealthEquity (HQY) to post quarterly earnings of $0.92 per share in its upcoming report, which indicates a year-over-year increase of 7%. Revenues are expected to be $318.81 million, up 6.3% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.Bearing this in mind, let's now explore the average estimates of specific HealthEquity metrics that are commonly monitored and projected by Wall Street analysts.Based on the collective assessment of analysts, 'Revenue- Service' should arrive at $116.04 million. The estimate suggests a change of -0.6% year over year.The consensus estimate for 'Revenue- Custodial' stands at $155.15 million. The estimate suggests a change of +11.9% year over year.Analysts' assessment points toward 'Revenue- Interchange' reaching $46.74 million. The estimate indicates a change of +5% from the prior-year quarter.The combined assessment of analysts suggests that 'Total HSA Assets' will likely reach $32.48 billion. Compared to the present estimate, the company reported $29.47 billion in the same quarter last year.The collective assessment of analysts points to an estimated 'Total HSA investments' of $14.78 billion. The estimate compares to the year-ago value of $13.10 billion.According to the collective judgment of analysts, 'CDBs Accounts' should come in at 6.88 million. Compared to the current estimate, the company reported 6.90 million in the same quarter of the previous year.Analysts predict that the 'Total Accounts' will reach 16.97 million. The estimate compares to the year-ago value of 16.28 million.The consensus among analysts is that 'Total HSA cash' will reach $17.70 billion. The estimate compares to the year-ago value of $16.37 billion.The average prediction of analysts places 'HSAs Accounts' at 10.10 million. The estimate compares to the year-ago value of 9.38 million. View all Key Company Metrics for HealthEquity here>>> Over the past month, shares of HealthEquity have returned -6.7% versus the Zacks S&P 500 composite's +1.3% change. Currently, HQY carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .Beyond Nvidia: AI's Second Wave Is HereThe AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. Little-known AI firms tackling the world's biggest problems may be more lucrative in the coming months and years.See "2nd Wave" AI stocks now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HealthEquity, Inc. (HQY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: HealthEquity und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf HealthEquity
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf HealthEquity
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Q2 Holdings Inc
Analysen zu Q2 Holdings Inc
Datum | Rating | Analyst | |
---|---|---|---|
13.08.2019 | Q2 Buy | Compass Point | |
01.03.2019 | Q2 Buy | Needham & Company, LLC | |
19.12.2018 | Q2 Buy | BTIG Research | |
09.08.2018 | Q2 Buy | Needham & Company, LLC | |
11.05.2018 | Q2 Neutral | BTIG Research |
Datum | Rating | Analyst | |
---|---|---|---|
11.05.2018 | Q2 Neutral | BTIG Research | |
18.11.2016 | Q2 Sector Weight | Pacific Crest Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Q2 Holdings Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen